BHB, namely β-hydroxybutyrate, is gathering attention in the medical investment field recently. As a type of ketone body, BHB is naturally produced in the human body during ketosis. Exogenous BHB supplements have shown potential health benefits and investment value. This article analyzes BHB investment from aspects of medical applications, product development, and future trends.
BHB helps treat diseases and disorders
Research has found that BHB can help treat major diseases and disorders like diabetes, epilepsy, Alzheimer’s disease, and more. For example, the ketogenic diet which induces ketosis and raises BHB levels has been used successfully to control drug-resistant epilepsy. The ability of BHB to provide alternative brain fuel and suppress inflammation is considered the key mechanism behind its neurological benefits. More clinical trials are underway to expand medical applications of BHB.
Large market for BHB supplements and products
The growing research on health effects of ketosis and BHB has driven strong demand for BHB supplements. Market research predicts the global exogenous ketone supplements market to reach $1.47 billion by 2028. More food, beverages and consumer products containing BHB are also being developed and marketed. The expanding applications of BHB create major investment opportunities.
BHB investments should focus on research and development
Most experts believe research and development will lead the advancement of the BHB industry. Investors may consider medical startups exploring novel BHB applications, manufacturers improving production methods, and consumer brands conducting safety studies, enhancing formulations and expanding product lines. These R&D focused companies will likely gain advantage in the blossoming BHB sector.
As a emerging player in the health supplement arena, BHB displays promising medical and commercial value. Investors are advised to seek out innovative companies dedicating in BHB research and product development to capitalize on this trend.